/
AVIR
$5.07+$0.01 (+0.20%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$404.9M
80M shares
52-week range
$2.78 – $6.45
62% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-22.81
Atea Pharmaceuticals, Inc. Common Stock
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
www.ateapharma.com- Employees
- 55
- IPO / List date
- Oct 30, 2020
- HQ
- BOSTON, MA
Held by traders on TradeandTell
No one on the platform currently holds AVIR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,166,400 | $6.3M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2018-02-14 | 1-for-11reverse |
Recent trades on TradeandTell
No one on the platform has traded AVIR yet.
